EP327: Statins, Co Enz, Q10, Sams and Metformin

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary Introduction Dr. Warwick Bishop hosts this episode focused on cardiovascular health and metabolic management, exploring the relationships between statins and coenzyme Q10, as well as the broader therapeutic potential of metformin. The episode examines recent research on how these medications affect muscle function, oxidative stress, and metabolic health, while emphasizing evidence-based approaches to disease prevention. Key Takeaways: Coenzyme Q10 (ubiquinone) is found throughout the body and is essential for mitochondrial function, but statin use significantly reduces muscle levels of this compound. A 12-week study found that baseline muscle coenzyme Q10 levels were lower in statin users compared to non-statin users, but these levels did not differ between those who experienced statin-related muscle symptoms and those who didn't. Exercise training increased muscle coenzyme Q10 levels across all groups regardless of statin use, suggesting that the lower coenzyme Q10 levels in statin users may not be the primary cause of muscle side effects. Moderate-intensity exercise is an effective strategy to boost muscle oxidative capacity and counteract oxidative stress associated with statins, benefiting all individuals regardless of medication use. Metformin demonstrates benefits beyond diabetes management, with emerging evidence suggesting potential reductions in cancer risk and Alzheimer's disease through improved insulin and glucose control. The benefits of metformin appear to be most pronounced in overweight individuals with prediabetes or insulin resistance, rather than as a universal preventive medication. Metformin is already established as beneficial for managing obesity, polycystic ovary syndrome, gestational diabetes, and weight gain from antipsychotic medications. The therapeutic effects of metformin likely stem from reducing hyperinsulinemia and elevated glucose levels, which contribute to cellular dysfunction across multiple organ systems.